• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.66% Nasdaq Down 1.05%

    Cytori Therapeutics, Inc. (CYTX)

    -NasdaqGM
    0.36 Down 0.01(3.49%) Sep 4, 4:00PM EDT
    Add to Portfolio
    Prev Close:0.37
    Open:0.38
    Bid:0.34 x 14700
    Ask:0.37 x 100
    1y Target Est:4.00
    Beta:4.3511
    Next Earnings Date:N/A
    Day's Range:0.36 - 0.38
    52wk Range:0.28 - 1.47
    Volume:1,860,953
    Avg Vol (3m):1,761,510
    Market Cap:59.26M
    P/E (ttm):N/A
    EPS (ttm):-0.34
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYTX

    Comparison

    Symbol% ChgMkt Cap
    CYTXDown 3.49%59.26M
    BAXDown 2.46%19.72B
    ASTM 0.00%N/A
    OSIRUp 1.60%635.75M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.23
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.24
    Quarterly EPS Est (Sep-15) :-0.06
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cytori Therapeutics, Inc., a biotechnology company, develops cell therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, includin... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback